ReShape Lifesciences Inc. (RSLS)
4.75
0.01 (0.21%)
At close: Jan 15, 2025, 1:40 PM
ReShape Lifesciences Inc. Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for RSLS stock have an median target of 0, with a low estimate of 0 and a high estimate of 0. The median target predicts a decrease of 0% from the current stock price of 4.75.
Analyst Consensus: Hold
AI Analyst Report
According to 1 stock analyst, the rating for ReShape Lifesciences Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
9.99M
from 8.68M
Increased by 15.2%
Revenue Next Year
11.99M
from 9.99M
Increased by 20.0%
EPS This Year
-26.1
from -110.88
Increased by 76.5%
EPS Next Year
-20.88
from -26.1
Increased by 20.0%